SUPERSEQUENCE
LIVE

Serial Number

97676693

Owner

Mediphage Bioceuticals, Inc.

Attorney

Monica Riva Talley

Filing Date

Nov 14, 2022

Add to watchlist:

No watchlists yet
View on USPTO

SUPERSEQUENCE Trademark

Serial Number: 97676693

SUPERSEQUENCE is a trademark filed by Mediphage Bioceuticals, Inc. on November 14, 2022. The trademark is classified under Class 1 (Chemicals). The application is currently pending registration.

Owner Contact Info

Mediphage Bioceuticals, Inc. (4 trademarks)

MaRS West Tower
Toronto, Ontario M5G0B7 , CA

Entity Type: 03

Trademark Details

Filing Date

November 14, 2022

Registration Date

Not Registered

Published for Opposition

October 1, 2024

Goods & Services

Biological preparations in the nature of artificial DNA sequences for use in biotechnology

Filing History

NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
Nov 27, 2025 EXRA
SOU EXTENSION 2 GRANTED
Nov 26, 2025 EX2G
SOU EXTENSION 2 FILED
Nov 26, 2025 EXT2
SOU TEAS EXTENSION RECEIVED
Nov 26, 2025 EEXT
NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
May 22, 2025 EXRA
SOU EXTENSION 1 GRANTED
May 21, 2025 EX1G
SOU EXTENSION 1 FILED
May 21, 2025 EXT1
SOU TEAS EXTENSION RECEIVED
May 21, 2025 EEXT
NOA E-MAILED - SOU REQUIRED FROM APPLICANT
Nov 26, 2024 NOAM
OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED
Oct 1, 2024 NPUB
PUBLISHED FOR OPPOSITION
Oct 1, 2024 PUBO
NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED
Sep 11, 2024 NONP
APPROVED FOR PUB - PRINCIPAL REGISTER
Aug 23, 2024 CNSA
TEAS/EMAIL CORRESPONDENCE ENTERED
May 15, 2024 TEME
CORRESPONDENCE RECEIVED IN LAW OFFICE
May 14, 2024 CRFA
TEAS RESPONSE TO OFFICE ACTION RECEIVED
May 14, 2024 TROA
APPLICATION EXTENSION GRANTED/RECEIPT PROVIDED
Feb 14, 2024 XELG
APPLICATION EXTENSION TO RESPONSE PERIOD - RECEIVED
Feb 14, 2024 XELR
NOTIFICATION OF NON-FINAL ACTION E-MAILED
Nov 14, 2023 GNRN
NON-FINAL ACTION E-MAILED
Nov 14, 2023 GNRT
NON-FINAL ACTION WRITTEN
Nov 14, 2023 CNRT
ASSIGNED TO EXAMINER
Aug 26, 2023 DOCK
NEW APPLICATION OFFICE SUPPLIED DATA ENTERED
Dec 5, 2022 NWOS
NEW APPLICATION ENTERED
Nov 17, 2022 NWAP